Skip to main content

Table 3 Iron study results before commencing treatment and on completion of treatment

From: Potentially effective therapy of heavy menstrual bleeding with an oestradiol-nomegestrol acetate oral contraceptive: a pilot study

 

Number

Mean

95% confidence interval

Median

Minimum

Maximum

P value (t test)

P value (signed rank)

HB before treatment

10

135.1

 

134.0

123

148

  

HB end of treatment

10

137.0

 

136.5

125

150

  

Difference (on-before)

10

1.9

−3.1, 6.7

3.5

−11

12

0.47

0.56

Transferrin before treatment

10

4.91

 

3.05

2.4

23

  

Transferrin on treatment

10

4.82

 

2.85

2.3

23.3

  

Difference (on-before)

10

−0.09

−0.25, 0.07

−0.05

−0.6

0.3

0.24

0.28

TIBC before treatment

10

64.2

 

66

54

76

  

TIBC on treatment

10

62.4

 

63

52

72

  

Difference (on-before)

10

1.8

−1.5, 5.1

1

−6

12

0.24

0.34

T-saturation before treatment

10

0.297

 

0.32

0.11

0.49

  

T-saturation on treatment

10

0.268

 

0.285

0.09

0.4

  

Difference (on-before)

10

−0.029

−0.128, 0.070

−0.095

−0.15

0.2

0.53

0.54

Ferritin before treatment

10

28.1

 

27

7

44

  

Ferritin on treatment

10

41

 

45.5

17

63

  

Difference (on-before)

10

12.9

5.9, 19.9

12.5

0

32

0.002

0.004

  1. A value of P <0.05 was taken as significant. This includes all values in italics